These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 36774339)
1. DNMT3a-dermatopontin axis suppresses breast cancer malignancy via inactivating YAP. Ye D; Wang Y; Deng X; Zhou X; Liu D; Zhou B; Zheng W; Wang X; Fang L Cell Death Dis; 2023 Feb; 14(2):106. PubMed ID: 36774339 [TBL] [Abstract][Full Text] [Related]
2. DNA methylation-mediated silencing of matricellular protein dermatopontin promotes hepatocellular carcinoma metastasis by α3β1 integrin-Rho GTPase signaling. Fu Y; Feng MX; Yu J; Ma MZ; Liu XJ; Li J; Yang XM; Wang YH; Zhang YL; Ao JP; Xue F; Qin W; Gu J; Xia Q; Zhang ZG Oncotarget; 2014 Aug; 5(16):6701-15. PubMed ID: 25149533 [TBL] [Abstract][Full Text] [Related]
3. Dermatopontin: a potential predictor for metastasis of human oral cancer. Yamatoji M; Kasamatsu A; Kouzu Y; Koike H; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K Int J Cancer; 2012 Jun; 130(12):2903-11. PubMed ID: 21796630 [TBL] [Abstract][Full Text] [Related]
4. Dermatopontin inhibits papillary thyroid cancer cell proliferation through MYC repression. Guo Y; Li H; Guan H; Ke W; Liang W; Xiao H; Li Y Mol Cell Endocrinol; 2019 Jan; 480():122-132. PubMed ID: 30391671 [TBL] [Abstract][Full Text] [Related]
5. DNMT3A Cooperates with YAP/TAZ to Drive Gallbladder Cancer Metastasis. Xu S; Yuan Z; Jiang C; Chen W; Li Q; Chen T Adv Sci (Weinh); 2024 Apr; 11(16):e2308531. PubMed ID: 38380551 [TBL] [Abstract][Full Text] [Related]
6. Dermatopontin is expressed in human liver and is downregulated in hepatocellular carcinoma. Li X; Feng P; Ou J; Luo Z; Dai P; Wei D; Zhang C Biochemistry (Mosc); 2009 Sep; 74(9):979-85. PubMed ID: 19916908 [TBL] [Abstract][Full Text] [Related]
7. circLIFR-007 reduces liver metastasis via promoting hnRNPA1 nuclear export and YAP phosphorylation in breast cancer. Zhang Y; Tan Y; Yuan J; Tang H; Zhang H; Tang Y; Xie Y; Wu L; Xie J; Xiao X; Li Y; Kong Y Cancer Lett; 2024 Jun; 592():216907. PubMed ID: 38685451 [TBL] [Abstract][Full Text] [Related]
8. SRGN crosstalks with YAP to maintain chemoresistance and stemness in breast cancer cells by modulating HDAC2 expression. Zhang Z; Qiu N; Yin J; Zhang J; Liu H; Guo W; Liu M; Liu T; Chen D; Luo K; Li H; He Z; Liu J; Zheng G Theranostics; 2020; 10(10):4290-4307. PubMed ID: 32292495 [No Abstract] [Full Text] [Related]
9. Long non‑coding RNA FOXD2‑AS1/miR‑150‑5p/PFN2 axis regulates breast cancer malignancy and tumorigenesis. Jiang M; Qiu N; Xia H; Liang H; Li H; Ao X Int J Oncol; 2019 Mar; 54(3):1043-1052. PubMed ID: 30628646 [TBL] [Abstract][Full Text] [Related]
10. A high level of the long non-coding RNA She Q; Chen Y; Liu H; Tan J; Li Y Bioengineered; 2022 May; 13(5):13437-13451. PubMed ID: 36700469 [TBL] [Abstract][Full Text] [Related]
11. Role of dermatopontin in re-epithelialization: implications on keratinocyte migration and proliferation. Krishnaswamy VR; Korrapati PS Sci Rep; 2014 Dec; 4():7385. PubMed ID: 25486882 [TBL] [Abstract][Full Text] [Related]
12. Dermatopontin is a novel regulator of the CdCl2-induced decrease in claudin-11 expression. Yang Q; Hao J; Chen M; Li G Toxicol In Vitro; 2014 Sep; 28(6):1158-64. PubMed ID: 24909373 [TBL] [Abstract][Full Text] [Related]
13. ARSD, a novel ERα downstream target gene, inhibits proliferation and migration of breast cancer cells via activating Hippo/YAP pathway. Lin Y; Li C; Xiong W; Fan L; Pan H; Li Y Cell Death Dis; 2021 Nov; 12(11):1042. PubMed ID: 34725332 [TBL] [Abstract][Full Text] [Related]
14. MCM6 is a critical transcriptional target of YAP to promote gastric tumorigenesis and serves as a therapeutic target. Wang Y; Chen H; Liu W; Yan H; Zhang Y; Cheung AHK; Zhang J; Chen B; Liang L; Zhou Z; Wong CC; Wu WKK; Chan MWY; Cheng ASL; Ma BBY; Yu J; Lo KW; To KF; Kang W Theranostics; 2022; 12(15):6509-6526. PubMed ID: 36185598 [No Abstract] [Full Text] [Related]
15. Dermatopontin promotes adhesion, spreading and migration of cardiac fibroblasts in vitro. Liu X; Meng L; Shi Q; Liu S; Cui C; Hu S; Wei Y Matrix Biol; 2013 Jan; 32(1):23-31. PubMed ID: 23262218 [TBL] [Abstract][Full Text] [Related]
16. Dermatopontin in Bone Marrow Extracellular Matrix Regulates Adherence but Is Dispensable for Murine Hematopoietic Cell Maintenance. Kramer AC; Blake AL; Taisto ME; Lehrke MJ; Webber BR; Lund TC Stem Cell Reports; 2017 Sep; 9(3):770-778. PubMed ID: 28844660 [TBL] [Abstract][Full Text] [Related]
17. Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility. Wang Z; Wu Y; Wang H; Zhang Y; Mei L; Fang X; Zhang X; Zhang F; Chen H; Liu Y; Jiang Y; Sun S; Zheng Y; Li N; Huang L Proc Natl Acad Sci U S A; 2014 Jan; 111(1):E89-98. PubMed ID: 24367099 [TBL] [Abstract][Full Text] [Related]
18. Dermatopontin in Skeletal Muscle Extracellular Matrix Regulates Myogenesis. Kim T; Ahmad K; Shaikh S; Jan AT; Seo MG; Lee EJ; Choi I Cells; 2019 Apr; 8(4):. PubMed ID: 30970625 [TBL] [Abstract][Full Text] [Related]
19. Silence of lncRNA MIAT-mediated inhibition of DLG3 promoter methylation suppresses breast cancer progression via the Hippo signaling pathway. Li D; Hu X; Yu S; Deng S; Yan M; Sun F; Song J; Tang L Cell Signal; 2020 Sep; 73():109697. PubMed ID: 32593652 [TBL] [Abstract][Full Text] [Related]
20. MST4 kinase suppresses gastric tumorigenesis by limiting YAP activation via a non-canonical pathway. An L; Nie P; Chen M; Tang Y; Zhang H; Guan J; Cao Z; Hou C; Wang W; Zhao Y; Xu H; Jiao S; Zhou Z J Exp Med; 2020 Jun; 217(6):. PubMed ID: 32271880 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]